# Actinium Pharmaceuticals, Inc.: Form 8-K/A, filed Mar 26, 2026

- Company: [Actinium Pharmaceuticals, Inc.](/companies/atnm.md) (CIK 1388320)
- Form: 8-K/A
- Filed: 2026-03-26
- Accepted by EDGAR: Mar 26, 2026, 21:00 ET
- Period: 2025-11-26
- Accession: 0001213900-26-034807
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1388320/000121390026034807/ea028303901-8ka_actinium.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1388320/000121390026034807/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1388320/000121390026034807/ea028303901-8ka_actinium.htm

Filed Mar 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-034807. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.